Violeta J Rodriguez1, Anne Shaffer1, Tae Kyoung Lee2, Karl Peltzer3,4, Stephen Marshall Weiss5, Deborah Lynne Jones5. 1. Department of Psychology, University of Georgia. 2. Department of Public Health Sciences, University of Miami Miller School of Medicine. 3. HIV/AIDS/STIs and TB (HAST) Research Programme, Human Sciences Research Council. 4. Department of Research & Innovation, University of Limpopo, Sovenga, South Africa. 5. Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine.
Abstract
PURPOSE: Women in South Africa also have high rates of depression and intimate partner violence, and they often co-occur. Women living with HIV who experience IPV are particularly likely to experience elevated levels of depressive symptoms and such symptoms are more likely to persist. Although the association between IPV and depression has been examined extensively, the role of depression on IPV has not. Therefore, this study examined the bidirectional association between intimate partner violence (IPV) and depression in South Africa (SA). METHOD: Participants were N=699 pregnant women with HIV in rural SA who completed measures of depressive symptoms and IPV at baseline (M=17.52±5.77 weeks of pregnancy), 32 weeks antenatally, and 6- and 12-months postnatally. RESULTS: Depressive symptoms were linked to increased psychological IPV from baseline to 32-weeks, and from 32-weeks to 6-months. However, from 6-months to 12-months, depressive symptoms were associated with decreased psychological IPV. Psychological IPV was linked to depressive symptoms from baseline to 32-weeks. Depressive symptoms were associated with physical IPV from 32-weeks to 6-months, and 6-months to 12-months. Physical IPV was associated with increased depressive symptoms from baseline to 32-weeks, and from 32-weeks to 6-months. CONCLUSIONS: Findings merit replication, as there may be measurement differences of psychological IPV in SA. However, targeting depressive symptoms and IPV concurrently in prevention and intervention programs may help optimize maternal and child outcomes in the context of prevention of mother-to-child transmission of HIV.
PURPOSE: Women in South Africa also have high rates of depression and intimate partner violence, and they often co-occur. Women living with HIV who experience IPV are particularly likely to experience elevated levels of depressive symptoms and such symptoms are more likely to persist. Although the association between IPV and depression has been examined extensively, the role of depression on IPV has not. Therefore, this study examined the bidirectional association between intimate partner violence (IPV) and depression in South Africa (SA). METHOD: Participants were N=699 pregnant women with HIV in rural SA who completed measures of depressive symptoms and IPV at baseline (M=17.52±5.77 weeks of pregnancy), 32 weeks antenatally, and 6- and 12-months postnatally. RESULTS: Depressive symptoms were linked to increased psychological IPV from baseline to 32-weeks, and from 32-weeks to 6-months. However, from 6-months to 12-months, depressive symptoms were associated with decreased psychological IPV. Psychological IPV was linked to depressive symptoms from baseline to 32-weeks. Depressive symptoms were associated with physical IPV from 32-weeks to 6-months, and 6-months to 12-months. Physical IPV was associated with increased depressive symptoms from baseline to 32-weeks, and from 32-weeks to 6-months. CONCLUSIONS: Findings merit replication, as there may be measurement differences of psychological IPV in SA. However, targeting depressive symptoms and IPV concurrently in prevention and intervention programs may help optimize maternal and child outcomes in the context of prevention of mother-to-child transmission of HIV.
Authors: Violeta J Rodriguez; Karl Peltzer; Gladys Matseke; Stephen M Weiss; Agnes Shine; Deborah L Jones Journal: Arch Womens Ment Health Date: 2018-05-23 Impact factor: 3.633
Authors: D S Metzger; B Koblin; C Turner; H Navaline; F Valenti; S Holte; M Gross; A Sheon; H Miller; P Cooley; G R Seage Journal: Am J Epidemiol Date: 2000-07-15 Impact factor: 4.897
Authors: C Lund; A Alem; M Schneider; C Hanlon; J Ahrens; C Bandawe; J Bass; A Bhana; J Burns; D Chibanda; F Cowan; T Davies; M Dewey; A Fekadu; M Freeman; S Honikman; J Joska; A Kagee; R Mayston; G Medhin; S Musisi; L Myer; T Ntulo; M Nyatsanza; A Ofori-Atta; I Petersen; S Phakathi; M Prince; T Shibre; D J Stein; L Swartz; G Thornicroft; M Tomlinson; L Wissow; E Susser Journal: Epidemiol Psychiatr Sci Date: 2015-04-02 Impact factor: 6.892
Authors: Karen M Devries; Joelle Y Mak; Loraine J Bacchus; Jennifer C Child; Gail Falder; Max Petzold; Jill Astbury; Charlotte H Watts Journal: PLoS Med Date: 2013-05-07 Impact factor: 11.069
Authors: Karl Peltzer; Stephen M Weiss; Manasi Soni; Tae Kyoung Lee; Violeta J Rodriguez; Ryan Cook; Maria Luisa Alcaide; Geoffrey Setswe; Deborah L Jones Journal: AIDS Res Ther Date: 2017-12-16 Impact factor: 2.250